NATCO PHARMA LTD. – 524816 – Announcement under Regulation 30 (LODR)-Press Release / Media Release

Source: BSE

Company: NATCO PHARMA LTD

USFDA COMPLETES INSPECTION OF NATCO’s MEKAGUDA ACTIVE PHARMACEUTICAL INGREDIENT FACILITY

Scrip Code: NATCOPHARM

Dear Sir,

Please find enclosed the Press Release for your information.

Click to View: – NATCO PHARMA LTD.

0 Reviews

Write a Review

Read Previous

Future Market – NSE- Announcements- GNFC Board Meetings

Read Next

KHAITAN CHEMICALS & FERTILIZERS LTD. – 507794 – Compliances-Reg. 39 (3) – Details of Loss of Certificate / Duplicate Certificate

Leave a Reply

Your email address will not be published. Required fields are marked *

Translate »